The presentation discusses the potential for investment in Bangladesh's pharmaceutical industry, which has become self-sufficient and meets 97% of domestic demand while contributing about 2% to GDP. The market has grown significantly, reaching $3 billion in 2020 and is projected to exceed $6 billion by 2025, with exports to over 100 countries. The government's support and increasing health care expenses are driving growth in the sector, which has been declared a priority area for development.

1. Welcome
to
the Presentation

2. Presentation
on
Potential sectors for Investment in Bangladesh (FDI) :
Pharmaceutical Industries
NAME ID
Md Tahsin Rahman Khan R232027
Akif Jafar R232024
Md. Farhan Islam R232017
Team Members

3. Introduction
Pharmaceutical industry is one of the most technologically advanced
and fast-growing sectors in Bangladesh. The industry took off in the
1980s after the formulation of the National Drug Policy 1982. Since
then, the industry has gradually succeeded in becoming self-sufficient
in the local market. At present, the industry meets 97% of the
domestic demand and contributes around 2% to the GDP. Currently,
there are 271 Allopathic, 205 Ayurvedic, 271 Unani, 32 Herbal and 79
Homeopathic drug producing companies in the country.

4. Objective
• To analyze the potential investment opportunities within the
pharmaceutical sector of Bangladesh.
• Pharmaceutical industry size and share in Bangladesh.
• Estimate the contribution of this industry to the total export
earnings.
• Estimate the growth projection of this industry.

5. Findings
Bangladesh Pharmaceutical Market Prior to 1982
Government Spending BDT 1,500 million per year
Number of brands in the market 3500
Number of manufacturers 177
Multinationals 8
Retail Pharmacists 16000
Number of Wholesalers 1300
Private Sector 90% available drugs
Government Utilize 10% available drugs
Source: Bangladesh Pharmacy Council (BPC), Annual Report

6. Investment Potential
Building from strength to strength, the pharmaceutical industry has grown from
about $25 million in 1982 to about $3 billion as of June 2020. Driven by the
increasing purchasing power of the domestic population, the domestic
pharmaceutical market is forecasted to exceed USD 6 billion by 2025. At present
the industry is serving 97 percent of the domestic market and exporting to more
than 100 countries around the world.

7. Company Market Size
(BDT Cr.)
Market Share
2023
Square Pharmaceuticals 5,404 17.63%
Incepta Pharmaceuticals 3,634 11.85%
Beximco Pharmaceuticals 2,918 9.52%
Healthcare Pharma 2,217 7.23%
Renata 1,501 4.89%
Opsonin Pharma 1,391 4.54%
Aristopharma 1,248 4.07%
Radiant Pharma 1,190 3.88%
Eskayef Bangladesh 1,166 3.80%
Acme Pharmaceutical 1,136 3.70%
ACI 1,154 3.76%
Drug International 997 3.25%
Popular Pharma 943 3.08%
Top Company Market Size and Share
Source: IQVIA MAT Q2 , 2023

8. Bangladesh Pharmaceutical Export
Bangladesh's pharmaceutical industry diversifies export market across
the globe with health products reaching 131 countries in the Asia-
Pacific region, Europe, America, Australia and Africa, insiders said.
The medicine manufacturers have already widened markets not only to
South Asian nations like Sri Lanka and Afghanistan but also booked a
share in the United States with the third-highest foreign-exchange
earnings from the world's largest economy, they said Wednesday.
Out of the country's total $175.425 million worth of pharmaceutical-
export earnings in the last fiscal year (FY) 2022-23, the local drug-
makers made a shipment worth $15.25 million to the US market,
Export Promotion Bureau (EPB) data showed.

10. Bangladesh India Vietnam Pakistan Nepal
$0
$20
$40
$60
$80
$100
$120
$140
$36
$63
$123
$40 $45
Per-capita Healthcare Spending
(at current prices in 2017)
Source: The World Bank

11. Growing global generic market for export of
branded generics drugs
Driven by growth in China, BRI, and other emerging nations, the global
pharmaceutical market is expected to grow at 5% per annum and reach USD
1,556 billion by 2023.The global generics segment, in particular, is expected to
grow at the rate of 8% per annum and reach USD 578 billion by 2023 from
USD 359 billion in 2017, contributing to almost 55% of the growth in the entire
pharma market between 2017 and 2023. Increasing health care expenses will be
driving the overall demand for generic drugs.
Although generic drugs are increasingly accepted by developed countries, the
ro h is expected to be more strongly driven by the emerging markets, where the
demana for generics is forecasted to grow at a rate of 9% per annum.

12. 2011 2012 2013 2014 2015
0
1000
2000
3000
4000
5000
6000
7000
3813.5
4212.25
4709.77
5773.07
6367.49
Drug Export in BDT (Million)
Export Trend (2011 - 2015)

14. Conclusion
The pharmaceutical sector has already been declared as the thrust
sector by the government of Bangladesh. Bangladesh has built a
strong baseline and going towards the self-sufficiency for the
production of medicine. In Bangladesh, the per-capita
consumption rate of medicine is one of the lowest in this earth.
However, since independence this industry has been a key
contributor to the Bangladeshi economy.

15. Thank you!